6-TAMRA
CAS No. 91809-67-5
6-TAMRA ( 6-Carboxytetramethylrhodamine )
Catalog No. M24966 CAS No. 91809-67-5
6-TAMRA has been a widely used fluorophore for preparing bioconjugates, especially fluorescent antibody and avidin derivatives used in immunochemistry.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 37 | In Stock |
|
25MG | 67 | In Stock |
|
50MG | 104 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name6-TAMRA
-
NoteResearch use only, not for human use.
-
Brief Description6-TAMRA has been a widely used fluorophore for preparing bioconjugates, especially fluorescent antibody and avidin derivatives used in immunochemistry.
-
Description6-TAMRA has been a widely used fluorophore for preparing bioconjugates, especially fluorescent antibody and avidin derivatives used in immunochemistry.
-
Synonyms6-Carboxytetramethylrhodamine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number91809-67-5
-
Formula Weight430.5
-
Molecular FormulaC25H22N2O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:2.86 mg/mL (6.64 mM; Need ultrasonic)
-
SMILESCN(C1=CC2=[O+]C3=C(C=CC(N(C)C)=C3)C(C4=CC(C([O-])=O)=CC=C4C(O)=O)=C2C=C1)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
VIR-165
VIR-165 is a modified form of virus inhibitory peptide (VIRIP), which corresponds to residues 353 to 372 of C-proximal region of human alpha1-antitrypsin, the most abundant circulating serine protease inhibitor. VIRIP inhibits a wide variety of human immunodeficiency virus type 1 (HIV-1) strains.
-
Eucomic acid
Eucomic acid showed the best inhibitory activity against the P. falciparum 3D7, a well-known chloroquine-sensitive strain.
-
Quassin
Quassin has female anti-fertility properties, possibly acting via inhibition of estrogen secretion.